Syntezza Bioscience

Company Overview

Snapshot

Founded in January 2004, Syntezza Bioscience operates with 11–50 employees. The company specializes in molecular biology products and services, serving the health tech and life sciences sector.

Business overview

Syntezza Bioscience provides molecular biology products and services, acting as an exclusive distributor for various offerings. Its product portfolio includes custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents, specifically designed for Next-Generation Sequencing (NGS) and CRISPR screens. The company also offers Sanger and NGS sequencing services and conducts contract research projects within the diagnostics field, primarily serving the pharmaceuticals and life sciences markets.

Company Intelligence Q&A

What is Syntezza Bioscience's primary focus?

Syntezza Bioscience focuses on providing molecular biology products and services, including custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents for NGS and CRISPR screens.

What types of sequencing services does Syntezza Bioscience offer?

Syntezza Bioscience offers both Sanger and Next-Generation Sequencing (NGS) services.

In which markets does Syntezza Bioscience primarily operate?

Syntezza Bioscience operates in the Israel and United States markets, serving the broader health tech and life sciences sector.

What is Syntezza Bioscience's employee count?

Syntezza Bioscience has 11–50 employees.

What is the primary sector of Syntezza Bioscience?

Syntezza Bioscience's primary sector is Health Tech & Life Sciences.